Literature DB >> 9358205

Assessment of antibiotic levels in lung tissue with erosion-controlled dosage forms.

M Saïdna1, E M Ouriemchi, J M Vergnaud.   

Abstract

The concentration-time curve of ciprofloxacin has been assessed in the blood compartment and in the lung tissue following oral administration of the drug. Immediate release and erosion-controlled dosage forms have been examined. A numerical model based on finite differences and taking into account all relevant data has been built: the kinetics of drug release in the gastrointestinal tract, drug absorption in the blood compartment and elimination, and the transient diffusion of the drug through the lung tissue. A partition coefficient for the drug at the tissue-blood interface has been considered to express the drug concentration at the tissue surface. The effect of dose frequency and erosion rate on the antibiotic versus time curves in the plasma and the lung tissue has been studied in detail.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358205     DOI: 10.1007/BF03189813

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  19 in total

1.  Reproducibility of the measurement of ciprofloxacin concentration in bronchial mucosa.

Authors:  J Winter; G Sweeney
Journal:  J Antimicrob Chemother       Date:  1991-03       Impact factor: 5.790

Review 2.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.

Authors:  J P Skelley; G L Amidon; W H Barr; L Z Benet; J E Carter; J R Robinson; V P Shah; A Yacobi
Journal:  J Pharm Sci       Date:  1990-09       Impact factor: 3.534

4.  Prediction of in-vivo blood level with controlled-release dosage forms. Effect of the gastrointestinal tract time.

Authors:  I M Ouriemchi; J M Vergnaud
Journal:  J Pharm Pharmacol       Date:  1996-04       Impact factor: 3.765

Review 5.  Pharmacokinetics of antibiotics in the lungs.

Authors:  Y Valcke; R Pauwels; M Van der Straeten
Journal:  Eur Respir J       Date:  1990-06       Impact factor: 16.671

Review 6.  In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications.

Authors:  J P Skelly; G F Shiu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

Review 7.  Pharmacokinetics of antibiotics in shallow and deep compartments.

Authors:  M Barza
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

Review 8.  Penetration of antibiotics into respiratory secretions.

Authors:  J E Pennington
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

9.  Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.

Authors:  R Rohwedder; T Bergan; E Caruso; S B Thorsteinsson; H Della Torre; H Scholl
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

10.  Tissue penetration of ciprofloxacin after single and multiple doses.

Authors:  M LeBel; F Vallée; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

View more
  1 in total

1.  Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage form.

Authors:  M Saïdna; E M Ouriemchi; J M Vergnaud
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.